International prescribing practices in obsessive-compulsive disorder (OCD).

Hum Psychopharmacol 2016 07 7;31(4):319-24. Epub 2016 Jun 7.

Department of Psychiatry, The University of Sydney and Nepean Hospital, Sydney Medical School-Nepean, Discipline of Psychiatry, Sydney/Penrith, NSW, Australia.

Objectives: To assess rates of psychotropic medication use in patients with obsessive-compulsive disorder (OCD) in seven different countries on five continents and to compare these with international treatment guidelines.

Methods: Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their patients with OCD and on their incidence of psychotropic use. Consistency of summary statistics across countries was evaluated.

Results: The data came from Brazil (n = 955), Italy (n = 750), South Africa (n = 555), Japan (n = 382), Australia (n = 213), India (n = 202) and Spain (n = 82). The majority (77.9%; n = 2445) of the total sample of 3139 participants received a psychotropic medication. Consistent with international guidelines, selective serotonin reuptake inhibitors (SSRIs) were most commonly used (73.5%, n = 1796), but their use ranged from 59% in Australia to 96% in Japan. Clomipramine use varied from 5% in Japan and South Africa to 26% in India and Italy. Atypical antipsychotic use ranged from 12% in South Africa to 50% in Japan.

Conclusions: Pharmacotherapy for OCD varied significantly across sites. Prospective studies are required to determine the cultural, pharmacoeconomic and pharmacogenomic factors that may play a role in the variation in prescribing practices internationally and whether these variations influence treatment outcomes. Copyright © 2016 John Wiley & Sons, Ltd.

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.2541DOI Listing
July 2016
45 Reads

Publication Analysis

Top Keywords

south africa
12
psychotropic medication
8
disorder ocd
8
prescribing practices
8
obsessive-compulsive disorder
8
summary statistics
8
ocd
5
3139 participants
4
pharmacoeconomic pharmacogenomic
4
sample 3139
4
total sample
4
pharmacogenomic factors
4
n = 2445 total
4
participants received
4
medication consistent
4
determine cultural
4
guidelines selective
4
international guidelines
4
consistent international
4
cultural pharmacoeconomic
4

References

(Supplied by CrossRef)

Brown et al.
1994
Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment
Burroughs et al.
J Natl Med Assoc 2002
Obsessive-compulsive disorder with poor insight: a three-year prospective study
Catapano et al.
Prog Neuropsychopharmacol Biol Psychiatry 2010
Ritual, a culture specific neurosis, and obsessional states in Bengali culture
Chakraborty et al.
Indian J Psychiatry 1975
Adults with early-onset obsessive-compulsive disorder
Do Rosario-Campos et al.
Am J Psychiatry 2001

Similar Publications